New codes from CMS help speed the reimbursement process. The following codes were approved after CPT 2010 went to press and are effective immediately: These new codes have been issued on an accelerated schedule to help ease the pressures of this year's unusual influenza season and will help to streamline the reporting and reimbursement procedures in administering nearly 200 million doses of the H1N1 vaccine in the U.S. They will also help to efficiently report and track immunization and counseling services related to the vaccine. "Remember to bill 90663 for $0 since the vaccine is provided free of charge by the federal government," says Alan L. Plummer, MD, professor of medicine in the division of pulmonary, allergy, and critical care at Emory University School of Medicine in Atlanta. "Providers will be paid for H1N1 vaccine administration (90470) and will have to check with each carrier to determine which codes to use." Switch to G Codes for Medicare For Medicare, if you're planning to administer the vaccination for H1N1, also known as the swine flu, the odds of collecting for the vaccine administration just improved. On Aug. 28, CMS released MLN Matters article MM6617, which introduces two new codes that apply to the H1N1 vaccine, as follows: • G9142 -- (Influenza A [H1N1] vaccine, any route of administration) is the code for the vaccine; • G9141 -- (Influenza A [H1N]) immunization administration [includes the physician counseling the patient/family]) refers to the vaccine administration. Remember: "Providers should report one unit of HCPCS code G9141 for each administration of the H1N1 vaccine," the MLN Matters article notes. Payment: "The reimbursement varies by state, but ranges from about $18 to $25," says Atlanta-based coding consultant Jay Neal. You can find your state's rate at: www.cms.hhs.gov/AdultImmunizations/Downloads/AdminRates09.pdf. Bonus: Check Your Primary Distribution The AMA is actively monitoring the most salient clinical information and recommendations on the flu and providing physicians with easy access to those sources for clinical use and communication with patients. The AMA's current advice to physicians is: • Antiviral treatment should be considered for high risk individuals with suspected influenza and said treatment should be started empirically. • Pregnant women are the most vulnerable and should be vaccinated with inactivated vaccine. • All healthcare workers should be vaccinated; LAIV (intranasal spray) is perfectly fine for use in healthcare workers. Note: For up-to-date information and resources, tailored for physicians, on seasonal and 2009 H1N1 influenza, visit www.amaH1N1info.org.